CAPTRUST Financial Advisors
RDY icon

CAPTRUST Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-165
Closed -$2K – 3603
2022
Q2 		$2K Hold
165
– – ﹤0.01% 4503
2022
Q1 		$2K Hold
165
– – ﹤0.01% 4529
2021
Q4 		$2K Hold
165
– – ﹤0.01% 4437
2021
Q3 		$2K Hold
165
– – ﹤0.01% 4292
2021
Q2 		$2K Buy
+165
New +$2.31K ﹤0.01% 4200

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CAPTRUST Financial Advisors's RDY Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2022, closing a stake of 165 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in RDY in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q2 2022. 151 funds tracked by Wall St. Rank hold RDY as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 165 Dr. Reddy's Laboratories shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Dr. Reddy's Laboratories position peaked at $2K in Q2 2022.
  • 151 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.